Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intransit Stage III/IV Melanoma

NCT01213732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With Intransit Stage III/IV Melanoma

Interventions

OTHER: Isolated inferior limb perfusion

Sponsor

Philogen S.p.A.

Collaborators

[object Object]
[object Object]